Specialty Pharmacy

Direct and indirect remuneration fees may not harm patients as recent reports have stated.

Supporters argue current laws are outdated and single out HIV-positive individuals.

A majority of cancer survivors felt telehealth services were beneficial.

Azathioprine exposure linked to myeloid neoplasm.

Why are some patients with cancer unresponsive to immunotherapies?

Low-dose computed tomography screenings remained very low and unchanged among eligible individuals.

Targeting skin sodium content may have beneficial effects on the heart in patients with kidney disease.

Special patient population produces new broadly neutralizing antibodies to defeat HIV.

Top news of the day from across the health care landscape.

Conventional HIV drugs could be transformed into once a month dosing.

Connection between arthritis and Crohn’s disease may lead to targeted treatment developments.

Eric Peacock, CEO of MyHealthTeams, discusses how the role patients take in their own care is rapidly evolving in the technological era.

Study findings shed new light on breast cancer treatments.

Creatine necessary for the replenishment of the intestinal mucosal barrier in IBD.

Top news from across the health care landscape.

Potential cancer drug class may bump standard practice of 1 drug, 1 target.

Squamous cell carcinoma carries a transcriptional fingerprint of basal cells.

Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Top news of the week in oncology and cancer drug development.

Interference with transcription factor activity may lead to the development of novel disease therapeutics.

Pharmaceutical Care Management Association states that direct and indirect remuneration fees lower premium costs.

Uterine cancers disseminated by surgical device.

Study opens doors for more precise RA treatments.

Roughly half of MS patients had hyposmia at the beginning of the study.

Lung cancer demonstration project examines the feasibility of a screening program for veterans.

Combination treatment reduces head and neck cancer deaths by 20%.

Treatment with protease inhibitors could result in HIV-associated neurocognitive diseases.

Top articles of the week on Specialty Pharmacy Times.